Bioreductive Activation of a Series of Indolequinones by Human DT-Diaphorase: Structure−Activity Relationships

This publication has 22 references indexed in Scilit:

• Disruption of the DT Diaphorase (NQO1) Gene in Mice Leads to Increased Menadione Toxicity
  Journal of Biological Chemistry, 1998
• Bioreductive activation of a series of analogues of 5-aziridinyl-3-hydroxymethyl-1-methyl-2-[1H-indole-4, 7-dione] prop-β-en-α-ol (EO9) by human DT-diaphorase
  Biochemical Pharmacology, 1996
• EO9 phase II study in advanced breast, gastric, pancreatic and colorectal carcinoma by the EORTC Early Clinical Studies Group
  European Journal Of Cancer, 1996
• A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity
  British Journal of Cancer, 1996
• Reductase Enzyme Expression Across the National Cancer Institute Tumor Cell Line Panel: Correlation With Sensitivity to Mitomycin C and EO9
  JNCI Journal of the National Cancer Institute, 1996
• Factors affecting sensitivity to EO9 in rodent and human tumour cells in vitro: DT-diaphorase activity and hypoxia
  European Journal Of Cancer, 1994
• DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9
  British Journal of Cancer, 1994
• Relative importance of DT-diaphorase and hypoxia in the bioactivation of e09 by human lung tumor cell lines
  International Journal of Radiation Oncology*Biology*Physics, 1994
• The sensitivity of human tumour cells to quinone bioreductive drugs: What role for DT-diaphorase?
  Biochemical Pharmacology, 1992
• The Role of NAD(P)H: Quinone Reductase (EC 1.6.99.2, DT-Diaphorase) in the Reductive Bioactivation of the Novel Indoloquinone Antitumor Agent E09
  Cancer Communications, 1991